Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
17
HCTI Quote, Financials, Valuation and Earnings
Last price:
$1.34
Seasonality move
:
-13.67%
Day range:
$1.85 - $1.97
52-week range:
$1.37 - $435.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.26x
P/B ratio:
8.60x
Volume:
196.9K
Avg. volume:
308.5K
1-year change:
-99.06%
Market cap:
$11.3M
Revenue:
$11.7M
EPS (TTM):
-$103.25
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Healthcare Triangle, Inc. has 159.07% upside to fair value with a price target of $6.00 per share.
HCTI vs. S&P 500
-
Over the past 5 trading days, Healthcare Triangle, Inc. has underperformed the S&P 500 by -17.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Healthcare Triangle, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Healthcare Triangle, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Healthcare Triangle, Inc. reported revenues of $3.5M.
Earnings Growth
-
Healthcare Triangle, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Healthcare Triangle, Inc. reported earnings per share of -$0.43.
Enterprise value:
18.6M
EV / Invested capital:
1.81x
Price / LTM sales:
0.26x
EV / EBIT:
--
EV / Revenue:
1.44x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.52x
Price / Operating cash flow:
3.39x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.6M
Return On Assets:
-67.37%
Net Income Margin (TTM):
-48.85%
Return On Equity:
-153.6%
Return On Invested Capital:
-116.94%
Operating Margin:
-74.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $37.4M | $16.6M | $12.9M | $2.4M | $3.5M | |
| Gross Profit | $4.2M | -$2.1M | $1.6M | $379K | $555K | |
| Operating Income | -$12.6M | -$9.3M | -$6.2M | -$1.2M | -$2.6M | |
| EBITDA | -$9.8M | -$3M | -$6.3M | -$824K | -$2.5M | |
| Diluted EPS | -$575.44 | -$2.16 | -$103.25 | -$0.22 | -$0.43 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.5M | $11.1M | $4.9M | $1.8M | $7.9M | |
| Total Assets | $11.4M | $24.9M | $14.5M | $4.8M | $13.8M | |
| Current Liabilities | $8.7M | $5.1M | $6.9M | $6.1M | $3.9M | |
| Total Liabilities | $8.7M | $7.3M | $8.3M | $6.6M | $5.1M | |
| Total Equity | $2.7M | $17.6M | $6.1M | -$1.8M | $8.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$7.8M | $944K | -$11M | $715K | -$2M | |
| Cash From Investing | $2.2M | -$6K | -$1.3M | -- | -$686K | |
| Cash From Financing | $1.6M | -$985K | $13.9M | -$716K | $1.1M | |
| Free Cash Flow | -$5.6M | $938K | -$12.3M | $715K | -$2.7M | |
HCTI
Sector
Market Cap
$11.3M
$27.9M
Price % of 52-Week High
0.44%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
-86.78%
-1.49%
1-Year Price Total Return
-99.06%
-16.66%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.19
200-day SMA
Sell
Level
$18.66
Bollinger Bands (100)
Sell
Level
1.95 - 3.41
Chaikin Money Flow
Sell
Level
-61.1M
20-day SMA
Sell
Level
$2.18
Relative Strength Index (RSI14)
Sell
Level
39.88
ADX Line
Sell
Level
12.13
Williams %R
Buy
Level
-89.0411
50-day SMA
Sell
Level
$2.42
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
77.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-28.3333)
Sell
CA Score
(Annual)
Level (-7.311)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (30.6323)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. It operates through the following segments: Software Services, Managed Services and Support, and Platform Services. The Software Services segment focuses on the sale of software services that are generated from providing strategic advisory, implementation, and development services. The Managed Services and Support segment includes post implementation support and cloud hosting. The Platform services segment offers solutions under CloudEz, DataEz, and Readabl.AI. The company was founded by Suresh Venkatachari and Keith T. Ryan on October 29, 2019 and is headquartered in Pleasanton, CA.
Stock Forecast FAQ
In the current month, HCTI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HCTI average analyst price target in the past 3 months is $6.00.
-
Where Will Healthcare Triangle, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Healthcare Triangle, Inc. share price will rise to $6.00 per share over the next 12 months.
-
What Do Analysts Say About Healthcare Triangle, Inc.?
Analysts are divided on their view about Healthcare Triangle, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Healthcare Triangle, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Healthcare Triangle, Inc.'s Price Target?
The price target for Healthcare Triangle, Inc. over the next 1-year time period is forecast to be $6.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HCTI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Healthcare Triangle, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HCTI?
You can purchase shares of Healthcare Triangle, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Healthcare Triangle, Inc. shares.
-
What Is The Healthcare Triangle, Inc. Share Price Today?
Healthcare Triangle, Inc. was last trading at $1.34 per share. This represents the most recent stock quote for Healthcare Triangle, Inc.. Yesterday, Healthcare Triangle, Inc. closed at $1.93 per share.
-
How To Buy Healthcare Triangle, Inc. Stock Online?
In order to purchase Healthcare Triangle, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HCTI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HCTI
Sector
P/E ratio
--
23.85x
PEG ratio
0.00x
-0.01x
P/B ratio
8.60x
1.81x
Price / LTM sales
0.26x
1.58x
Growth Metrics
HCTI
Sector
Revenue growth
44.59%
4.62%
Earnings growth
-94.6%
10.7%
Revenue (5-year growth)
-16.46%
6.5%
Earnings forecast
-$0.22
-$0.21
Profitability
HCTI
Sector
Profitability FY 2024
$2M
$3.6M
Return on invested capital
-116.94%
-31.87%
Return on assets
-67.37%
-28.18%
Return on equity
-153.6%
-37.63%
Earnings Date
Last Earnings Date
Dec
22
Next Earnings Date
Dec
22
Estimated Next Earnings Date
Mar
23
Balance Sheet
HCTI
Sector
Total cash
$1.6M
$26.4M
Short term investments
--
$25.7M
Total assets
$2M
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
